Camelot Portfolios, LLC Bausch Health Companies Inc. Transaction History

Camelot Portfolios, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$6.1 - $10.41 $51,850 - $88,485	8,500 New	8,500 $59,000
Q3 2023 Oct 20, 2023	SELL	$7.69 - $9.71 $65,365 - $82,535	-8,500 Reduced 29.82%	20,000 $164,000
Q2 2023 Jul 25, 2023	BUY	$5.72 - $8.8 $40,040 - $61,600	7,000 Added 32.56%	28,500 $228,000
Q4 2022 Jan 25, 2023	BUY	$6.09 - $7.93 $30,450 - $39,650	5,000 Added 30.3%	21,500 $0
Q3 2022 Oct 31, 2022	SELL	$4.58 - $9.21 $34,350 - $69,075	-7,500 Reduced 31.25%	16,500 $114,000
Q2 2022 Jul 18, 2022	BUY	$7.06 - $23.63 $169,440 - $567,120	24,000 New	24,000 $201,000
Q2 2021 Jul 28, 2021	SELL	$27.43 - $32.7 $281,706 - $335,829	-10,270 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$21.37 - $34.38 $233,125 - $375,051	-10,909 Reduced 51.51%	10,270 $326,000
Q4 2020 Jan 27, 2021	BUY	$15.31 - $21.12 $26,914 - $37,128	1,758 Added 9.05%	21,179 $441,000
Q3 2020 Oct 19, 2020	BUY	$14.88 - $20.13 $288,984 - $390,944	19,421 New	19,421 $302,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.